Daniel Barber is President and CEO of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 845,364 shares of AQST, which is worth approximately $3.04 Million. The most recent transaction as insider was on Mar 09, 2024, when has been sold 37,938 shares (Common Stock) at a price of $4.88 per share, resulting in proceeds of $185,137. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 845K
0% 3M change
31.94% 12M change
Total Value Held $3.04 Million

Daniel Barber Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 09 2024
SELL
Payment of exercise price or tax liability
$185,137 $4.88 p/Share
37,938 Reduced 4.3%
845,364 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
242,600 Added 21.55%
883,302 Common Stock
Mar 09 2023
BUY
Grant, award, or other acquisition
-
447,000 Added 41.1%
640,702 Common Stock
Jun 08 2022
BUY
Open market or private purchase
$88,073 $0.96 p/Share
91,743 Added 32.14%
193,702 Common Stock
DB

Daniel Barber

President and CEO
Warren, NJ

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Track Activities on AQST